Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to determine the efficacy of one single intravenous injection of 4g of V0251 on vertigo symptoms relief in patient presenting with an attack of acute vertigo from vestibular origin.
Critère d'inclusion
- V0251 is a new antivertiginous agent which is being developed for the treatment of symptomatic vertiginous crisis